Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Hemophilia Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Product (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others), By Therapy (Replacement Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Replacement Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Hemophilia Therapeutics market size is poised to register 7.38% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Beta Thalassemia Market Assessment, By Type [Beta Thalassemia Minor, Beta Thalassemia Intermedia, Beta Thalassemia Major], By Therapy [Blood Transfusions, Iron Chelation Therapy, Folic Acid Supplements, Gene Therapy, Bone Marrow Transplants], By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies], By Region, Opportunities and Forecast, 2017-2031F
... Retail Pharmacies, Online Pharmacies], By Region, Opportunities and Forecast, 2017-2031F Global beta thalassemia market is projected to witness a CAGR of 7.75% during the forecast period 2024-2031F, growing from USD 503 million in 2023, to ... Read More
-
Global Diamond–Blackfan Anemia (DBA) Treatment Market - 2024-2031
... YY% during the forecast period 2024-2031. Pure red cell aplasia is the defining feature of Diamond Blackfan anemia (DBA), a congenital form of anemia linked to congenital bone defects. This anemia is persistent macrocytic-normocytic. 40 ... Read More
-
Thalassemia testing market - 2024-2031
... 2024-2031. Thalassemia is characterized by a genetic deficiency in the synthesis of alpha and beta-globin chains. The signs and symptoms of thalassemia appear within the first 2 years of life and many people with thalassemia ... Read More
-
Global Thalassemia Gene Test Kit Supply, Demand and Key Producers, 2024-2030
... during the forecast period (2024-2030). Thalassemia Gene Test Kit is a diagnostic tool used to detect genetic mutations associated with thalassemia, a group of blood disorders that affect hemoglobin production. Hemoglobin is a protein in ... Read More
-
Global Thalassemia Gene Test Kit Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Thalassemia Gene Test Kit is a diagnostic tool used to detect ... Read More
-
Global Chemotherapy Induced Anemia Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Chemotherapy Induced Anemia is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Thalassemia Market Size, Trends, Analysis, and Outlook By Treatment Type (Iron Chelation Therapy, Others), By Type (Alpha Thalassemia, Beta Thalassemia), By Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Thalassemia market size is poised to register 10.51% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Sickle Cell Anemia Testing and Screening Market Size, Trends, Analysis, and Outlook By Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography, Point-of-Care Tests), By Age group (Newborn Screening, Adult Screening, Others), By Sector (Government Labs, Private Labs, Corporate Labs, Public-Private-Partnerships), by Region, Country, Segment, and Companies, 2024-2030
... Corporate Labs, Public-Private-Partnerships), by Region, Country, Segment, and Companies, 2024-2030 The global Sickle Cell Anemia Testing and Screening market size is poised to register 13.73% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Prenatal and Newborn Genetic Testing Market Size, Trends, Analysis, and Outlook By Product (Consumables, Instruments), By Screening (Non-invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Others), By Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), By End-user (Hospital, Maternity and Specialty Clinics, Diagnostic centers), by Region, Country, Segment, and Companies, 2024-2030
... Sickle Cell Anemia), By End-user (Hospital, Maternity and Specialty Clinics, Diagnostic centers), by Region, Country, Segment, and Companies, 2024-2030 The global Prenatal and Newborn Genetic Testing market size is poised to register 12.69% growth from ... Read More
-
Autologous Cell Therapy Market Size, Trends, Analysis, and Outlook By Therapy , Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Application (Oncology, Musculoskeletal Disorder, Blood Disorder, Autoimmune Disease, Others), By Source (Bone Marrow, Epidermis, Others), By End-User (Hospitals, Research Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... By End-User (Hospitals, Research Centers, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Autologous Cell Therapy market size is poised to register 18.41% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Hemoglobinopathies Market Size, Trends, Analysis, and Outlook By Type (Thalassemia, Sickle Cell Disease, Others), By Therapy (Monoclonal Antibody Medication, ACE inhibitors, Hydroxyurea, Others), By Distribution Channel (Hospital Pharmacy, Online Providers, Drug Stores and Retail Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Hemoglobinopathies market size is poised to register 10.81% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Rare Hemophilia Factors Market Size, Trends, Analysis, and Outlook By Type (Factor I, Factor II, Factor V, Factor VII, Factor X, Factor XI, Factor XIII), By Treatment (Factor Concentrates, Fresh Frozen Plasma, Cryoprecipitate, Others), by Region, Country, Segment, and Companies, 2024-2030
... Region, Country, Segment, and Companies, 2024-2030 The global Rare Hemophilia Factors market size is poised to register 6.43% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... 5.81% during the period spanning 2024-2028. The growth in the market has been driven by factors like increasing healthcare expenditure, surging identified hemophilia patient volume, increased focus on prophylactic treatment, rise in male population and ... Read More
-
Sickle Cell Disease Treatment Market Size, Trends, Analysis, and Outlook By Drug Type (Hydroxyurea, Oxybryta, Adakveo, Others), By Type (Sickle Cell Anemia, HbSC, Others), By Route of Administration (Oral, Parenteral), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Sickle Cell Disease Treatment market size is poised to register 17.39% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
The 2025-2030 World Outlook for Hemophilia a Gene Therapies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hemophilia a Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hemophilia Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Hematological Disorder Drugs and Diagnostics
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Bleeding Disorder Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Dual Chamber Prefilled Syringes Market Forecasts to 2030 – Global Analysis By Product Type (Conventional Prefilled Syringes, Safety Prefilled Syringes and Other Product Types), Type (<1 ml, 1 ml-2.5 ml, 2.5 ml-5.0 ml, >5.0 ml and Other Types), Indication (Hemophilia, Schizophrenia, Diabetes, Erectile Dysfunction, Endometriosis and Other Indications), Material, Distribution Channel, Application and by Geography
... Erectile Dysfunction, Endometriosis and Other Indications), Material, Distribution Channel, Application and by Geography According to Stratistics MRC, the Global Dual Chamber Prefilled Syringes Market is accounted for $168.72 million in 2023 and is expected to ... Read More
-
The 2025-2030 World Outlook for Thalassemia Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Blood Plasma Fractionation
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Renal Anemia Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hemophilia
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
Research Assistance
